This approval allows Lupin to introduce a generic version of Esbriet® tablets in the same strengths, which are originally manufactured by Hoffmann La Roche Inc. The manufacturing of this product is scheduled to take place at Lupin’s Pithampur facility located in India.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment